Grants per year
Personal profile
Research Interests
I am a general academic pediatrician in the Department of Pediatrics.
I study the natural history and treatment of optic pathway tumors in children who have neurofibromatosis-1. My clinic is a site of the Department of Defense Neurofibromatosis Clinical Trials Consortium which conducts clinical trials on individuals with NF-1, NF-2 and schwannomatosis. I am very involved in the education program of the Department of Pediatrics
My main clinical focuses are: 1) The care and management of children with Neurofibromatosis-1 2) Consultative pediatrics for difficult diagnostic problems 3) The management of hospitalized children
Certifications and Licenses
| Pediatrics |
Training Experience
| 1982 | Residency, Northwestern University, McGaw Medical Center (Children’s Memorial Hospital) |
Education/Academic qualification
MD, Medicine, University of Pennsylvania
… → 1979
Research interests keywords
- Neurofibromatosis
Fingerprint
Dive into the research topics where Robert H Listernick is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Grants
- 6 Finished
-
A Study of INFUSE Bone Graft (recombinant human Bone Morphogenetic Protein-2/absorbable collagen sponge) in the treatment of Tibial Pseudarthrosis in Neurofibromatosis 1 (NF1)
Goldman, S. (PD/PI), Janicki, J. A. (PD/PI), King, E. (PD/PI), Listernick, R. H. (PD/PI) & Sarwark, J. F. (PD/PI)
University of Alabama at Birmingham, Department of Defense
5/15/16 → 5/14/19
Project: Research project
-
A Study of INFUSE Bone Graft (recombinant human Bone Morphogenetic Protein-2/absorbable collagen sponge) in the treatment of Tibial Pseudarthrosis in Neurofibromatosis 1 (NF1)
Goldman, S. (PD/PI), Janicki, J. A. (PD/PI), King, E. (PD/PI), Listernick, R. H. (PD/PI) & Sarwark, J. F. (PD/PI)
University of Alabama at Birmingham, Department of Defense
5/15/16 → 5/14/19
Project: Research project
-
A Study of INFUSE Bone Graft (recombinant human Bone Morphogenetic Protein-2/absorbable collagen sponge) in the treatment of Tibial Pseudarthrosis in Neurofibromatosis 1 (NF1)
Goldman, S. (PD/PI), Janicki, J. A. (PD/PI), King, E. (PD/PI), Listernick, R. H. (PD/PI) & Sarwark, J. F. (PD/PI)
University of Alabama at Birmingham, Department of Defense
5/15/16 → 5/14/19
Project: Research project
-
Developing Evidence-Based Criteria for Initiating Treatment for NF1-OPG
Pillay Smiley, N. (PD/PI) & Listernick, R. H. (Co-Investigator)
9/1/15 → 8/31/20
Project: Research project
-
Development of Patient Reported Outcomes System for Children and Young Adults with pNF Using Mixed Method Approach
Charrow, J. (PD/PI) & Listernick, R. H. (Co-Investigator)
Northwestern University, Johns Hopkins University
2/1/14 → 1/31/16
Project: Research project
-
Expanding the phenotype of neurofibromatosis type 1 microdeletion syndrome
Garzon, J. P., Patete, A., Aschbacher-Smith, L., Qu'd, D., Kelly-Mancuso, G., Raski, C. R., Weisman, A. G., Hankins, M., Sawin, M., Kim, K. H., Drackley, A., Zeid, J., Weaver, K. N., Hopkin, R. J., Saal, H. M., Charrow, J., Schorry, E., Listernick, R., Simpson, B. N. & Prada, C. E., 2024, (Accepted/In press) In: American Journal of Medical Genetics, Part C: Seminars in Medical Genetics.Research output: Contribution to journal › Article › peer-review
Open Access -
Ocular ischemic syndrome in neurofibromatosis type 1 treated with corticosteroids
Zhang, D. L., Listernick, R. H. & Rahmani, S., Aug 2023, In: Journal of AAPOS. 27, 4, p. 239-242 4 p.Research output: Contribution to journal › Article › peer-review
-
Management of neurofibromatosis type 1-associated plexiform neurofibromas
Fisher, M. J., Blakeley, J. O., Weiss, B. D., Dombi, E., Ahlawat, S., Akshintala, S., Belzberg, A. J., Bornhorst, M., Bredella, M. A., Cai, W., Ferner, R. E., Gross, A. M., Harris, G. J., Listernick, R., Ly, I., Martin, S., Mautner, V. F., Salamon, J. M., Salerno, K. E. & Spinner, R. J. & 6 others, , Nov 1 2022, In: Neuro-oncology. 24, 11, p. 1827-1844 18 p.Research output: Contribution to journal › Review article › peer-review
Open Access40 Scopus citations -
Risk factors for treatment-refractory and relapsed optic pathway glioma in children with neurofibromatosis type 1
Kotch, C., Avery, R., Getz, K. D., Bouffet, E., De Blank, P., Listernick, R., Gutmann, D. H., Bornhorst, M., Campen, C., Liu, G. T., Aplenc, R., Li, Y. & Fisher, M. J., Aug 1 2022, In: Neuro-oncology. 24, 8, p. 1377-1386 10 p.Research output: Contribution to journal › Article › peer-review
Open Access13 Scopus citations -
Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation
International Consensus Group on Neurofibromatosis Diagnostic Criteria (I-NF-DC), Sep 2022, In: Genetics in Medicine. 24, 9, p. 1967-1977 11 p.Research output: Contribution to journal › Article › peer-review
Open Access82 Scopus citations